Following a consultation earlier this year, the one pension mention in the Budget was about ‘patient’ capital investing, a means of encouraging pension schemes and members to invest in innovative firms for the long term. Aegon highlights the challenges posed by patient capital for schemes and individuals. Steven Cameron, Pensions Director at Aegon comments on whether pensions are appropriate sources of investments here |
“The Government seems keen to encourage pension schemes and potentially members to make long term ‘patient capital’ investments to help innovative firms secure long term investment. For occupational pensions, trustees must be left to decide if they are appropriate for their scheme and its beneficiaries, and certainly for defined benefit, this depends on likely future outflows to pay benefits. “The Pensions Regulator is to clarify its guidance on how trustees can invest in assets with long-term investment horizons as part of a diversified portfolio. We trust this guidance will reflect the illiquid nature of these investments. Larger schemes have more scope to diversify and patient capital investment may have relatively more appeal to them as a result. “One of the main challenges of this form of investment is that the companies or assets are rarely priced daily, so there’s uncertainty over their daily value. For those in defined contribution schemes where members buy and sell units in investment vehicles daily this is a challenge. “There have also been suggestions from parts of the industry that individuals should be allowed to make patient capital investments even if they have reached their pension lifetime allowance. Most people in this position will be closer to retirement meaning liquidity is particularly key if they intend to use their pension to generate an income. Furthermore, investment diversification is important for any pension investor, and forcing any pension investments above the lifetime allowance into patient capital could lead to too much concentration in a single asset.
“We are strongly in favour of an increase in, or removal of, the lifetime allowance, but would be concerned about introducing a concession just for patient capital. Pension policy and rules should be designed to support retirement provision, not made more complicated to generate investments in a minority sector, however positive this might be for the economy. Whatever the outcome, if anyone is considering patient capital investment, it’s essential they seek advice.” |
|
|
|
Pensions Data Science Actuary | ||
Offices UK wide, hybrid working - Negotiable |
Head of Pricing | ||
London - Negotiable |
Global Specialty Pricing Actuary | ||
London - £95,000 Per Annum |
Client-facing DC investment manager | ||
London / hybrid 3 dpw office-based - Negotiable |
Financial Risk Leader - Bermuda | ||
Bermuda - Negotiable |
Aylesbury Actuaries | ||
Aylesbury / hybrid 3dpw office-based - Negotiable |
Make an impact in protection pricing ... | ||
London / hybrid 2 days p/w office-based - Negotiable |
BPA Implementation Manager | ||
North / hybrid 50/50 - Negotiable |
Head of Reserving | ||
London - £160,000 Per Annum |
In-force Longevity Actuarial Analyst | ||
London / hybrid 2 dpw office-based - Negotiable |
Make a difference within reinsurance ... | ||
London / hybrid 2 dpw office-based - Negotiable |
Be at the cutting-edge of life & heal... | ||
London / hybrid 2 dpw office-based - Negotiable |
Longevity Pricing Analyst | ||
London / hybrid 2 dpw office-based - Negotiable |
Develop your career in life reinsuran... | ||
London / hybrid 2 dpw office-based - Negotiable |
Protection Pricing Actuary - Life Rei... | ||
London / hybrid 2 dpw office-based - Negotiable |
Life (Re)insurance Pricing Manager (P... | ||
London / hybrid 2 dpw office-based - Negotiable |
Take the lead: life & health reinsura... | ||
London / hybrid 2 dpw office-based - Negotiable |
Pricing Tools and Systems Developer | ||
London / hybrid 2 dpw office-based - Negotiable |
Longevity Pricing Actuary | ||
London / hybrid 2 dpw office-based - Negotiable |
Shape the future of longevity | ||
London / hybrid 2 dpw office-based - Negotiable |
Be the first to contribute to our definitive actuarial reference forum. Built by actuaries for actuaries.